Peer-reviewedLicence not statedCochrane Database of Systematic Reviews
Prostate-specific antigen (PSA) test for prostate cancer screening
9 affiliations
- 1Cochrane Evidence Synthesis Unit Germany/UK – Düsseldorf Subunit, Institute of General Practice; Heinrich Heine University Düsseldorf; Düsseldorf Germany
- 2Department of Urology; Chonnam National University Medical School, Chonnam National University Hwasun Hospital; Hwasun Korea, South
- 3Center of Evidence-Based Medicine, Institute of Convergence Science; Yonsei University; Seoul Korea, South
- 4Department of Urology; Yonsei University Wonju College of Medicine; Wonju Korea, South
- 5School of Medicine; Universidad del Hospital Italiano de Buenos Aires; Buenos Aires Argentina
- 6Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine; Monash University; Melbourne Australia
- 7Velindre NHS Trust; Cardiff University Library Services; Cardiff UK
- 8Department of Urology; University of Minnesota; Minneapolis Minnesota USA
- 9Urology Section; Minneapolis VA Health Care System; Minneapolis Minnesota USA
Related
- Case Report: Prostatic infarction mimicking prostate cancer in a patient with markedly elevated prostate-specific antigen
- Cohort profile: the Prostate-Specific Antigen Cohort (PSA Cohort) and the Prostate Cancer Risk Cohort (ProCaRis Cohort) - cohorts based on Danish health data
- Primary Prostatic Diffuse Large B-Cell Lymphoma Mimicking Prostate Cancer With a Normal Prostate-Specific Antigen Level.
- [18F]F-Prostate-specific Membrane Antigen-1007 and [68Ga] Ga-Prostate-specific Membrane Antigen-11 Positron Emission Tomography in Prostate Cancer: Do Standardized Uptake Value Correlations Dictate Choice?
- Multi-Cycle Dosimetry of the Albumin-Binding Prostate-Specific Membrane Antigen Ligand [¹⁷⁷Lu]Ludotadipep in Metastatic Androgen Pathway Modulator-Resistant Prostate Cancer with Adjusted Red Marrow Modeling.
BibTeX
@article{franco2026prostatespecific,
title = {{Prostate-specific antigen (PSA) test for prostate cancer screening}},
author = {Juan Víctor Ariel Franco and Eu Chang Hwang and Jae Hung Jung and Octavio Vaimberg and Dragan Ilić and Anne Cleves and Philipp Dahm},
journal = {Cochrane Database of Systematic Reviews},
year = {2026},
month = may,
doi = {10.1002/14651858.cd004720.pub4},
url = {https://pubmed.ncbi.nlm.nih.gov/42134821/},
}
RIS
TY - JOUR
TI - Prostate-specific antigen (PSA) test for prostate cancer screening
AU - Juan Víctor Ariel Franco
AU - Eu Chang Hwang
AU - Jae Hung Jung
AU - Octavio Vaimberg
AU - Dragan Ilić
AU - Anne Cleves
AU - Philipp Dahm
PY - 2026
DA - 2026/05/15
JO - Cochrane Database of Systematic Reviews
DO - 10.1002/14651858.cd004720.pub4
UR - https://pubmed.ncbi.nlm.nih.gov/42134821/
SN - 1361-6137
SN - 1464-780X
SN - 1465-184X
SN - 1465-1858
SN - 1469-493X
ER -